Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Funbio is a probiotic formulation developed and marketed by Switzer Life Science, primarily available as a dry syrup for pediatric use. The active ingredient is *Lactic Acid Bacillus* (also known as *Bacillus coagulans*), a spore-forming bacterium that is resistant to gastric acid and colonizes the intestinal tract. Funbio is used to restore the natural balance of gut microbiota, which can be disrupted by infections or antibiotic use. It is commonly indicated for the management of acute diarrhea, antibiotic-associated diarrhea, and various digestive disorders such as indigestion and irritable bowel syndrome (IBS). By producing lactic acid and competing with pathogenic bacteria for nutrients and adhesion sites, it helps maintain a healthy intestinal environment and supports immune function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactic acid bacillus.